Author:
Oshikoya Kazeem A.,Wharton Gerold T.,Avant Debbie,Van Driest Sara L.,Fenn Norman E.,Lardieri Allison,Doe Edwin,Sood Beena G.,Taketomo Carol,Lieu Phuong,Yen Lilly,McMahon Ann W.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pediatrics, Perinatology, and Child Health
Reference30 articles.
1. Sachs A, Avant D, Lee C, Rodriguez W, Murphy D. Research letter: pediatric information in drug product labeling. JAMA. 2012;307(18):1914–5.
2. Ufer M, Kimland E, Bergman U. Adverse drug reactions and off-label prescribing for paediatric outpatients: a one-year survey of spontaneous reports in Sweden. Pharmacoepidemiol Drug Saf. 2004;13:147–52.
3. Bellis JR, Kirkham JJ, Nunn AJ, Pirmohamed M. Adverse drug reactions and off-label and unlicensed medicines in children: a prospective cohort study of unplanned admissions to a paediatric hospital. Br J Clin Pharmacol. 2014;77:545–53.
4. Aagaard L. Off-label and unlicensed prescribing of medicines in pediatric populations: occurrence and safety aspects. Basic Clin Pharmacol Toxicol. 2015;117(4):215–8.
5. Food and Drug Administration, HHS. 21 CFR 314.80: Post marketing reporting of adverse drug experiences 2017.
https://www.gpo.gov/fdsys/pkg/CFR-2011-title21-vol5/pdf/CFR-2011-title21-vol5-sec314-80.pdf
. Accessed 30 Jul 2017.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献